beta-lactams has been researched along with Chlamydia Infections in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Deenen, R; Deepe, GS; Eder, T; Friedrich, D; Grebien, F; Günther, UL; Isay, SE; Käding, N; Kaufhold, I; Klinger, M; Köhrer, K; Ogunsulire, IM; Rattei, T; Richer, BC; Rupp, J; Schmidt, N; Shima, K | 1 |
Hall, J; Kintner, J; Lajoie, D; Schoborg, RV; Whittimore, J | 1 |
Robbie, MO; Schachter, J; Sweet, RL | 1 |
Eschenbach, D; Holmes, KK; Paavonen, J; Wølner-Hanssen, P | 1 |
4 other study(ies) available for beta-lactams and Chlamydia Infections
Article | Year |
---|---|
Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam Antimicrobials.
Topics: Anti-Bacterial Agents; beta-Lactams; Chlamydia Infections; Chlamydia trachomatis; Fatty Acids; HeLa Cells; Humans; Mitochondria; STAT3 Transcription Factor | 2021 |
Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations.
Topics: Anti-Bacterial Agents; beta-Lactams; Cell Line; Cells, Cultured; Chlamydia Infections; Chlamydia trachomatis; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Penicillins; RNA, Ribosomal, 16S; Stress, Physiological | 2014 |
Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis.
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Chlamydia Infections; Chlamydia trachomatis; Drug Resistance, Microbial; Endometrium; Female; Humans; Salpingitis | 1983 |
Treatment of pelvic inflammatory disease: use doxycycline with an appropriate beta-lactam while we wait for better data.
Topics: Anti-Bacterial Agents; beta-Lactams; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Drug Therapy, Combination; Female; Humans; Pelvic Inflammatory Disease | 1986 |